Antibacterial activity of wild Xylaria sp. strain R005 (Ascomycetes) against multidrug-resistant Staphylococcus aureus and Pseudomonas aeruginosa

International Journal of Medicinal Mushrooms

Volumn 14, Issue 1, 2012, Pages 47-53

  Ramesh, Veluchamy ^a   Ezhil Arivudainambi, U S ^a   Thalavaipandian, Annamalai ^a   Karunakaran, Chandran ^a   Rajendran, Ayyappan ^a  

^a VHNSN COLLEGE   (India)

Author keywords

Antibacterial activity; Fruiting bodies; Medicinal mushrooms; Multidrug resistant strains; Pesudomonas aeruginosa; Staphylococcus aureus; Xylaria sp.

Indexed keywords

AMIKACIN; CEFOTAXIME; CIPROFLOXACIN; FUNGAL EXTRACT; METICILLIN; OFLOXACIN; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN; XYLARIA EXTRACT; ACETIC ACID DERIVATIVE; ACETIC ACID ETHYL ESTER; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; ASCOMYCETES; BACTERIAL STRAIN; DISK DIFFUSION; DRUG POTENTIATION; FUNGAL STRUCTURES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; XYLARIA; CHEMISTRY; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE;

ASCOMYCOTA; BACTERIA (MICROORGANISMS); BASIDIOMYCOTA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; XYLARIA;

ACETATES; ANTI-BACTERIAL AGENTS; ASCOMYCOTA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84859496109     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v14.i1.50     Document Type: Article

References (25)

1. Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med. 2005;33(8):1845-53.
2. Tenover FC, Gaynes RP. The epidemiology of Staphylococcus infections. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA and Rood JL, Eds. Gram-positive pathogens. Washington DC: ASM Press; 2000. p. 414-21.
3. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43(5):2384-90.
4. Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med. 1999;20(2):303-16.
5. Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med. 2001;29(4):114-20.
6. Paladino JA, Sunderlin JL, Price CS, Schentag JJ. Economicconsequences of antimicrobial resistance. Surg Infect (Larchmt). 2002;3(3):259-67.
7. Korvick JA, Yu VL. Antimicrobial agent therapy for Pseudomonas saeruginosa. Antimicrob Agents Chemother. 1991;35(11):2167-72.
8. Strobel GA, Daisy B. Bioprospecting for microbial endophytes and their natural products. Microbiol Mol Biol Rev. 2003;67(4):491-502.
9. Smith CJ, Morin NR, Bills GF, Dombrowski AW, Salituro GM, Smith SK, Zhao A, MacNeil DJ. Novel sesquiterpenoids from the fermentation of Xylaria persicaria are selective ligands for the NPY Y5 receptor. J Org Chem. 2002;67(14):5001-4.
10. Lin Y, Wu X, Feng S, Jiang G, Zhou S, Vrijmoed LLP, Gareth Jones EB. A novel N-cinnamoylcyclopeptide containing an allenic ether from the fungus Xylaria sp. (strain #2508) from the South China Sea. Tetrahedron Lett. 2001;42(3):449-51.
11. Pittayakhajonwut P, Suvannakad R, Thienhirun S, Prabpai S, Kongsaeree P, Tanticharoen M. An anti-herpes simplex virus-type 1 agent from Xylaria mellisii (BCC 1005). Tetrahedron Lett. 2005;46(8):1341-44.
12. Park, Hyeop J, Choi GJ, Lee HB, Kim KM, Jung HS, Lee SJ, Jang KS, Cho KY, Kim JC. Griseofulvin from Xylaria sp. strain F0010, an endophytic fungus of Abies holophylla and its antifungal activity against plant pathogenic fungi. J Micobiol Biotechnol. 2005;15(1):112-17.
13. Wang XN, Tan RX, Liu JK. Xylactam, a new nitrogen-containing compound from the fruiting bodies of ascomycete Xylaria euglossa. J Antibiot. 2005;58(4):268-70.
14. Shiono Y, Motoki S, Koseki T, Murayama T, Tojima M, Kimura KI. Isopimarane diterpene glycosides, apoptosis inducers, obtained from fruiting bodies of the ascomycete Xylaria polymorpha. Phytochem. 2009;70(7):935-39.
15. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403-10.
16. Acar JF, Goldstein FW. Disk susceptibility test. In: Lorian V, editor. Antibiotics in boratory medicine. 3 ed. Baltimore, Williams & Wilkins; 1991. p. 17-52.
17. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing, fifteenth informational supplement. Document M100-S15, 25 ed. Wayne, PA: CLSI; 2005. p. 138-39.
18. Al-bayati FA. Synergistic antibacterial activity between Thymus vulgaris and Pimpinella anisum essential oils and methanol extracts. J Ethnopharmacol. 2008;116(3):403-6.
19. White RL, Burgess DS, Mandruru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: Time-kill, checkerboard and E-test. Antimicrob Agents Chemother. 1996;40(8):1914-18.
20. Odds FC. Synergy, antagonism and what the checkerboard puts between them. J Antimicrob Chemother. 2003;52(1):1.
21. Hacioglu N, Akata I,Dulger B. Antimicrobial potential of Xylaria polymorpha (Pers.) Grev. Afr J Microbiol Res. 2011;5(6):728-30.
22. Espada A, Sagredo AR, Fuente JM, Rodriguez JAD, Elson SW. New cytochalasins from the fungus Xylaria hypoxylon. Tetrahedron. 1997; 53 (18): 6485-92.
23. Romero CJE, Barria EO, Arnold AE, Rios LC. Activity against Plasmodium falciparum of lactones isolated from the endophytic fungus Xylaria sp. Pharm Biol. 2008;46(11):1-4.
24. Maja K, Neda MD, Petar K, Zorica S, Milan M. Antibacterial properties of selected lignicolous mushrooms and fungi from northern Serbia. Int J Med Mushr. 2009;11(3):269-79.
25. Liu X, Dong M, Chen X, Jiang M, Lv X, Zhou J. Antimicrobial activity of an endophytic Xylaria sp.YX-28 and identification of its antimicrobial compound 7-amino-4-methylcoumarin. Appl Microbiol Biotechnol. 2008;78(2):241-47.